explore -WSS

explore

author：explore 2025-09-30 21:57:12 - browse：5963

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Readout LOUD podcast, live from the STAT Breakthrough Summit East

hotspot

WSS

Surgeons perform first xenotransplant using CRISPR'd pig kidney

What to do when lifesaving products contribute to climate change

Biotech investment managers search for lucrative opportunities

Medicare Advantage insurers pressure Biden for bigger payments

How to pay for weight loss drugs and save Medicare

30 years of 'Listening to Prozac'

hotspot

explore

explore

Medicare proposal to cover medical devices draws a mixed reaction

The EPA's new lead rule: How one expert crunched the numbers

Jerome Adams on the need for new antivirals for Covid

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Hepatitis C has a cure — but many Americans still lack access to it

Fetal surgery at risk from Dobbs and new abortion restrictions

New air purifier tech could be key to improving indoor air quality

Medical devices makers are asking for forgiveness, not permission

ChatGPT in medicine: STAT answers readers' burning questions

CRISPR technology availability, affordability needs to be expanded

hotspot

Asbestos ban is immediate, but health effects will linger for decades

Pediatric cancer treatments threatened by a new FDA policy

CDC director unscathed in first congressional testimony

The EPA's new lead rule: How one expert crunched the numbers

Medicare Advantage insurers pressure Biden for bigger payments

What Kate Middleton's cancer revelation might teach the world

explore

hotspot

hotspot

explore